Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $51.10 million. The enterprise value is $13.75 million.

Market Cap	51.10M
Enterprise Value	13.75M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

JSPR has 27.92 million shares outstanding. The number of shares has increased by 19.90% in one year.

Current Share Class	27.92M
Shares Outstanding	27.92M
Shares Change (YoY)	+19.90%
Shares Change (QoQ)	+2.08%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	37.68%
Float	23.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.26
P/TBV Ratio	2.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.09.

Current Ratio	2.10
Quick Ratio	1.93
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -146.87% and return on invested capital (ROIC) is -91.65%.

Return on Equity (ROE)	-146.87%
Return on Assets (ROA)	-73.30%
Return on Invested Capital (ROIC)	-91.65%
Return on Capital Employed (ROCE)	-362.21%
Revenue Per Employee	n/a
Profits Per Employee	-$1.42M
Employee Count	64
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.83% in the last 52 weeks. The beta is 3.05, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	3.05
52-Week Price Change	-91.83%
50-Day Moving Average	2.43
200-Day Moving Average	4.14
Relative Strength Index (RSI)	31.95
Average Volume (20 Days)	376,215

Short Selling Information

The latest short interest is 1.55 million, so 5.54% of the outstanding shares have been sold short.

Short Interest	1.55M
Short Previous Month	1.51M
Short % of Shares Out	5.54%
Short % of Float	6.54%
Short Ratio (days to cover)	3.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-94.05M
Pretax Income	-90.92M
Net Income	-90.92M
EBITDA	-92.73M
EBIT	-94.05M
Earnings Per Share (EPS)	-$6.02

Balance Sheet

The company has $39.51 million in cash and $2.16 million in debt, giving a net cash position of $37.36 million or $1.34 per share.

Cash & Cash Equivalents	39.51M
Total Debt	2.16M
Net Cash	37.36M
Net Cash Per Share	$1.34
Equity (Book Value)	23.50M
Book Value Per Share	1.45
Working Capital	22.47M

Cash Flow

In the last 12 months, operating cash flow was -$73.48 million and capital expenditures -$377,000, giving a free cash flow of -$73.86 million.

Operating Cash Flow	-73.48M
Capital Expenditures	-377,000
Free Cash Flow	-73.86M
FCF Per Share	-$2.64

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.90%
Shareholder Yield	-19.90%
Earnings Yield	-177.93%
FCF Yield	-144.53%

Analyst Forecast

The average price target for JSPR is $28.00, which is 1,430.06% higher than the current price. The consensus rating is "Buy".

Price Target	$28.00
Price Target Difference	1,430.06%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1